ProteoNic and Genencor Sign Research Agreement
ProteoNic and Genencor, a Danisco Division, have signed a research agreement. As part of the contract, the two biotech companies will use ProteoNic’s UNic™ Toolbox to investigate enzyme production for Genencor’s fungal Expression platforms. ProteoNic will support Genencor in applying the unique protein yield enhancement products.
Victor Schut, Proteonic CEO: “The enzyme market is focused on product quality and competitive pricing. Genencor is a leader in this market, and their decision to team with us to improve the cost structure of their production will allow us to prove our leadership in this field. It will also further substantiate our track record in the field of fungal production systems. This partnership will demonstrate the value of combining molecular biology expertise (mRNA optimization) with extensive experience in large-scale production process optimization.”
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.